LNTH

Lantheus Holdings, Inc. is a prominent biotechnology company headquartered in North Billerica, Massachusetts, specializing in the development and commercialization of advanced diagnostic and therapeutic solutions, primarily targeting oncology and cardiology. Recognized for its innovative PET imaging agents, Lantheus is pivotal in enhancing the accuracy of cancer diagnosis and treatment management, thereby significantly improving patient outcomes. With a commitment to advancing healthcare through cutting-edge technology, Lantheus has solidified its position as a key player within the healthcare sector, driving innovation and improving patient care across its therapeutic focus areas.